The Global Cardiac Rhythm Management Devices Market is projected to reach USD 17.3 billion in 2024 which is further anticipated to reach USD 31.0 billion by 2033 at a CAGR of 6.5%. The Global Cardiac ...

Global Cardiac Rhythm Management (CRM) Devices Market Size: The global cardiac rhythm management (CRM) devices catered the revenue figure of nearly USD 19 billion in the year 2021 and is estimated to ...

The global cardiac rhythm management market is on a strong upward trajectory, with new projections indicating that the market will expand from USD 24.7 billion in 2024 to USD 36.7 billion by 2034, ...

Antiarrhythmic medications used to maintain sinus rhythm have long been the treatment of choice in atrial fibrillation. The results of five prospective randomized trials comparing the efficacy and ...

LONDON--(BUSINESS WIRE)--The cardiac rhythm management (CRM) devices market is poised to grow by USD 3.73 billion during 2020-2024, progressing at a CAGR of almost 5% during the forecast period.

Boston Scientific’s (NYSE: BSX) Rhythm Management & Neuro segment accounts for around 30% of the company’s value, according to our estimates. The segment primarily includes products such as pacemakers ...

The management of patients with atrial fibrillation involves three main areas: anticoagulation, rate control and rhythm control. Importantly, these are not mutually exclusive of each other.

New research examined a large-scale national registry of cardiac arrest cases to measure the effects of advanced airway management (AAM) on one-month outcomes after patients survived. The deep ...

Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med ...

Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Cardiac Rhythm Management Market. The study features insights on ...